P50443 (S26A2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 119.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sulfate transporter Alternative name(s): Diastrophic dysplasia protein Solute carrier family 26 member 2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 739 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Sulfate transporter. May play a role in endochondral bone formation. |
| Subcellular location | |
| Tissue specificity | Ubiquitously expressed. |
| Involvement in disease | Defects in SLC26A2 are the cause of diastrophic dysplasia (DTD) [MIM:222600]. DTD is an autosomal recessive disease characterized by osteochondrodysplasia with clinical features including dwarfism, spinal deformation, and specific joint abnormalities. Defects in SLC26A2 are the cause of achondrogenesis type 1B (ACG1B) [MIM:600972]. ACG1B is a recessively inherited chondrodysplasia characterized by extremely poor skeletal development and perinatal death. Ref.9 Defects in SLC26A2 are the cause of atelosteogenesis type 2 (AO2) [MIM:256050]; also known as neonatal osseous dysplasia 1. AO2 is characterized by severely shortened limbs, small chest, scoliosis, club foot of the equinovarus type (talipes equinovarus), abducted thumbs and great toes, and cleft palate. Patients die of respiratory insufficiency shortly after birth because of the collapse of the airways and pulmonary hypoplasia due to the small rib cage. Ref.10 Defects in SLC26A2 are the cause of multiple epiphyseal dysplasia type 4 (EDM4) [MIM:226900]. EDM is a generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. EDM is broadly categorized into the more severe Fairbank and the milder Ribbing types. EDM4 is a recessively inherited form, characterized by early childhood-onset hip dysplasia and recurrent patella dislocation. Short stature in EDM4 patients is not frequent. Ref.12 Ref.13 |
| Sequence similarities | Belongs to the SLC26A/SulP transporter (TC 2.A.53) family. [View classification] Contains 1 STAS domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation Dwarfism |
| Domain | Transmembrane Transmembrane helix |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular component | integral to plasma membrane Traceable author statement. Source: ProtInc membrane fractionTraceable author statement. Source: ProtInc |
| Molecular function | secondary active sulfate transmembrane transporter activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 739 | 739 | Sulfate transporter | PRO_0000080158 | |||||
Regions | |||||||||
| Topological domain | 1 – 111 | 111 | Cytoplasmic Potential | ||||||
| Transmembrane | 112 – 132 | 21 | Helical; Potential | ||||||
| Topological domain | 133 – 136 | 4 | Extracellular Potential | ||||||
| Transmembrane | 137 – 157 | 21 | Helical; Potential | ||||||
| Topological domain | 158 – 159 | 2 | Cytoplasmic Potential | ||||||
| Transmembrane | 160 – 180 | 21 | Helical; Potential | ||||||
| Topological domain | 181 – 218 | 38 | Extracellular Potential | ||||||
| Transmembrane | 219 – 239 | 21 | Helical; Potential | ||||||
| Topological domain | 240 – 241 | 2 | Cytoplasmic Potential | ||||||
| Transmembrane | 242 – 262 | 21 | Helical; Potential | ||||||
| Topological domain | 263 – 296 | 34 | Extracellular Potential | ||||||
| Transmembrane | 297 – 317 | 21 | Helical; Potential | ||||||
| Topological domain | 318 – 328 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 329 – 349 | 21 | Helical; Potential | ||||||
| Topological domain | 350 – 377 | 28 | Extracellular Potential | ||||||
| Transmembrane | 378 – 398 | 21 | Helical; Potential | ||||||
| Topological domain | 399 – 420 | 22 | Cytoplasmic Potential | ||||||
| Transmembrane | 421 – 441 | 21 | Helical; Potential | ||||||
| Topological domain | 442 – 454 | 13 | Extracellular Potential | ||||||
| Transmembrane | 455 – 475 | 21 | Helical; Potential | ||||||
| Topological domain | 476 – 523 | 48 | Cytoplasmic Potential | ||||||
| Transmembrane | 524 – 544 | 21 | Helical; Potential | ||||||
| Topological domain | 545 – 643 | 99 | Extracellular Potential | ||||||
| Transmembrane | 644 – 664 | 21 | Helical; Potential | ||||||
| Topological domain | 665 – 739 | 75 | Cytoplasmic Potential | ||||||
| Domain | 568 – 719 | 152 | STAS | ||||||
Amino acid modifications | |||||||||
| Modified residue | 12 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 16 | 1 | Phosphoserine Ref.7 Ref.8 | ||||||
| Glycosylation | 199 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 205 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 357 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 255 | 1 | G → E in AO2. Ref.10 | VAR_007434 | |||||
| Natural variant | 256 | 1 | F → S in EDM4. Ref.13 | VAR_066835 | |||||
| Natural variant | 279 | 1 | R → W in AO2 and EDM4. Ref.10 Ref.13 | VAR_007435 | |||||
| Natural variant | 340 | 1 | Missing in ACG1B. | VAR_007436 | |||||
| Natural variant | 425 | 1 | N → D in ACG1B. Ref.9 | VAR_007437 | |||||
| Natural variant | 454 | 1 | Q → P in diatrophic dysplasia; broad bone-platyspondylic variant. Ref.11 | VAR_018654 | |||||
| Natural variant | 574 | 1 | I → T. Ref.1 Ref.2 Ref.5 Corresponds to variant rs30832 [ dbSNP | Ensembl ]. | VAR_058415 | |||||
| Natural variant | 653 | 1 | C → S in EDM4. Ref.12 Ref.13 | VAR_018655 | |||||
| Natural variant | 678 | 1 | G → V in ACG1B. Ref.9 | VAR_007438 | |||||
| Natural variant | 689 | 1 | T → S. Corresponds to variant rs3776070 [ dbSNP | Ensembl ]. | VAR_020402 | |||||
| Natural variant | 715 | 1 | A → V in AO2 and EDM4. Ref.10 Ref.13 | VAR_007439 | |||||
Experimental info | |||||||||
| Sequence conflict | 619 | 1 | R → G in CAE45819. Ref.6 | ||||||
| Sequence conflict | 622 | 1 | K → R in BAG35488. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping." Haestbacka J., de la Chapelle A., Mahtani M.M., Clines G., Reeve-Daly M.P., Daly M., Hamilton B.A., Kusumi K., Trivedi B., Weaver A., Coloma A., Lovett M., Buckler A., Kaitila I., Lander E.S. Cell 78:1073-1087(1994) [PubMed: 7923357] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT THR-574. Tissue: Brain. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT THR-574. Tissue: Tongue. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed: 15372022] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT THR-574. Tissue: Placenta. |
| [6] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 614-739. Tissue: Prostate. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-16, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene." Superti-Furga A., Haestbacka J., Wilcox W.R., Cohn D.H., van der Harten H.J., Rossi A., Blau N., Rimoin D.L., Steinmann B., Lander E.S., Gitzelmann R. Nat. Genet. 12:100-102(1996) [PubMed: 8528239] [Abstract] Cited for: VARIANTS ACG1B VAL-340 DEL; ASP-425 AND VAL-678. |
| [10] | "Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias." Haestbacka J., Superti-Furga A., Wilcox W.R., Rimoin D.L., Cohn D.H., Lander E.S. Am. J. Hum. Genet. 58:255-262(1996) [PubMed: 8571951] [Abstract] Cited for: VARIANTS AO2 GLU-255; TRP-279 AND VAL-715. |
| [11] | "Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia." Megarbane A., Haddad F.A., Haddad-Zebouni S., Achram M., Eich G., Le Merrer M., Superti-Furga A. Clin. Genet. 56:71-76(1999) [PubMed: 10466420] [Abstract] Cited for: VARIANT DIATROPHIC DYSPLASIA PRO-454. |
| [12] | "Autosomal recessive multiple epiphyseal dysplasia with homozygosity for C653S in the DTDST gene: double-layer patella as a reliable sign." Maekitie O., Savarirayan R., Bonafe L., Robertson S., Susic M., Superti-Furga A., Cole W.G. Am. J. Med. Genet. A 122:187-192(2003) [PubMed: 12966518] [Abstract] Cited for: VARIANT EDM4 SER-653. |
| [13] | "Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution." Jackson G.C., Mittaz-Crettol L., Taylor J.A., Mortier G.R., Spranger J., Zabel B., Le Merrer M., Cormier-Daire V., Hall C.M., Offiah A., Wright M.J., Savarirayan R., Nishimura G., Ramsden S.C., Elles R., Bonafe L., Superti-Furga A., Unger S., Zankl A., Briggs M.D. Hum. Mutat. 0:0-0(2011) [PubMed: 21922596] [Abstract] Cited for: VARIANTS EDM4 SER-256; TRP-279; SER-653 AND VAL-715. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U14528 mRNA. Translation: AAA70081.1. AK290358 mRNA. Translation: BAF83047.1. AK312596 mRNA. Translation: BAG35488.1. AC008427 Genomic DNA. No translation available. CH471062 Genomic DNA. Translation: EAW61755.1. BC059390 mRNA. Translation: AAH59390.1. BX640696 mRNA. Translation: CAE45819.1. |
| IPI | IPI00032107. |
| PIR | A54808. |
| RefSeq | NP_000103.2. NM_000112.3. |
| UniGene | Hs.302738. |
3D structure databases | |
| ProteinModelPortal | P50443. |
| SMR | P50443. Positions 548-723. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | P50443. |
Protein family/group databases | |
| TCDB | 2.A.53.2.1. sulfate permease (SulP) family. |
PTM databases | |
| PhosphoSite | P50443. |
Polymorphism databases | |
| DMDM | 254763328. |
Proteomic databases | |
| PRIDE | P50443. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000286298; ENSP00000286298; ENSG00000155850. |
| GeneID | 1836. |
| KEGG | hsa:1836. |
Organism-specific databases | |
| CTD | 1836. |
| GeneCards | GC05P149320. |
| H-InvDB | HIX0005307. |
| HGNC | HGNC:10994. SLC26A2. |
| HPA | HPA041957. |
| MIM | 222600. phenotype. 226900. phenotype. 256050. phenotype. 600972. phenotype. 606718. gene. |
| neXtProt | NX_P50443. |
| Orphanet | 93298. Achondrogenesis type 1B. 56304. Atelosteogenesis type II. 628. Diastrophic dwarfism. 93307. Multiple epiphyseal dysplasia type 4. |
| PharmGKB | PA149. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG14800. |
| GeneTree | ENSGT00570000078891. |
| HOGENOM | HBG446299. |
| HOVERGEN | HBG000639. |
| InParanoid | P50443. |
| OMA | TSDRICD. |
| OrthoDB | EOG4BZN22. |
| PhylomeDB | P50443. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | P50443. |
| Bgee | P50443. |
| CleanEx | HS_SLC26A2. |
| Genevestigator | P50443. |
| GermOnline | ENSG00000155850. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018045. S04_transporter_CS. IPR002645. SO4_transptr/STAS. IPR001902. SulP_transpt. IPR011547. Sulph_transpt. [Graphical view] |
| Gene3D | G3DSA:3.30.750.24. STAS. 2 hits. |
| KO | K14701. |
| Pfam | PF01740. STAS. 1 hit. PF00916. Sulfate_transp. 1 hit. [Graphical view] |
| SUPFAM | SSF52091. STAS. 1 hit. |
| TIGRFAMs | TIGR00815. SulP. 1 hit. |
| PROSITE | PS01130. SLC26A. 1 hit. PS50801. STAS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 7495. |
| SOURCE | Search... |
Entry information
| Entry name | S26A2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P50443 Secondary accession number(s): A8K2U3, B2R6J1, Q6N051 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with